Johnson & Johnson's Janssen COVID-19 Vaccine: Authorized for Emergency Use
The Janssen COVID-19 Vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized by FDA through an Emergency Use Authorization (EUA) for active immunization to prevent Coronavirus Disease 2019 (COVID-19) in individuals 18 years of age and older for whom other FDA-authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and in individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not receive a COVID-19 vaccine. The Janssen COVID-19 Vaccine can cause blood clots with low levels of platelets (blood cells that help your body stop bleeding), which may be fatal.
Want to Learn More About Johnson & Johnson's Janssen COVID‑19 Vaccine and Relevant Booster Dose Information?DISCOVER MORE
Can I Get Johnson & Johnson's Janssen COVID‑19 Vaccine?FIND OUT
Looking for Information
Need COVID‑19 Resources?DISCOVER MORE
COVID-19=coronavirus disease 2019.